U.S. Hepatitis C Market Published: October 2011 No. of Pages: 75 Price: $ 6000
This research service covers the U.S. hepatitis C (HCV) market from 2008 to 2016, with 2010 as the base year. Included are products on the market, products in development, and patient and revenue forecasts. Market challenges, drivers, and restraints are identified and assessed. The market is segmented by classes of drug: interferons, protease inhibitors, nucleotide polymerase inhibitors, non-nucleotide polymerase inhibitors, NS5a's, and other classes. Included are examinations of therapeutic candidates on the market and in the HCV late-stage pipeline. Executive Summary 4 Market Overview 10 Total Market • External Challenges: Drivers and Restraints 16 • Forecasts and Trends 26 • Demand Analysis 39 • Market Share and Competitive Analysis 41 Peginterferon alfa and Ribavirin Segment Breakdown 54 Protease Inhibitor Segment Breakdown 60 The Last Word 66 Appendix 70 About Us: ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports. Follow us on Twitter: http://twitter.com/marketsreports Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689 Contact: Mr.Priyank
7557 Rambler road, Suite727,Dallas,TX75231 Tel: + 1 888 391 5441 E-mail: sales@reportsandreports.com http://www.reportsnreports.com Visit our Market Research Blog